Literature DB >> 31264108

Impact of opium dependency on clinical and neuropsychological indices of multiple sclerosis patients.

Fatemeh Ayoobi1,2, Reza Bidaki3,4, Ali Shamsizadeh5, Amir Moghadam-Ahmadi6, Houshang Amiri7,8.   

Abstract

The aim of this study was to determine the effect of opium on clinical and neuropsychological parameters in multiple sclerosis (MS) patients with substance dependency. A cross-sectional study was conducted on MS patients in Rafsanjan, Iran. Forty opium-addict MS patients (10 males and 30 females) aged between 18 and 50 years were compared with 40 MS patients with no addiction. Word-Pair Learning, Mini-Mental State Examination (MMSE), Wisconsin Card-Sorting Test (WCST), Depression, Anxiety, Expanded Disability Status Scale (EDSS), Fatigue, and the Multiple Sclerosis Functional Composite (MSFC) were measured and compared in the two groups. The comparison of two groups showed a significant increase trait anxiety (P < 0.001), fatigue (P = 0.009) and significant decrease in the executive function (P = 0.003), MMSE (P = 0.003), and working memory (P < 0.001) in addicted MS. It indicates the better efficiency of processing in the non-addicted MS patients. The MSFC z-score also was significantly higher in the non-addicted group (P < 0.001). The opium addiction has a negative impact on the clinical and neuropsychological outcome in MS patients.

Entities:  

Keywords:  Addiction; Cognition; Multiple sclerosis; Opium; Substance dependency

Mesh:

Year:  2019        PMID: 31264108     DOI: 10.1007/s10072-019-03971-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  BEHAVIORAL STUDY OF OBEDIENCE.

Authors:  S MILGRAM
Journal:  J Abnorm Psychol       Date:  1963-10

Review 3.  Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.

Authors:  Elon Eisenberg; Ewan D McNicol; Daniel B Carr
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

4.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

5.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

6.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; L A Alvarez; N G LaRocca; L C Scheinberg
Journal:  Arch Neurol       Date:  1988-04

Review 7.  Opioid dependence and addiction during opioid treatment of chronic pain.

Authors:  Jane C Ballantyne; Steven K LaForge
Journal:  Pain       Date:  2007-05-04       Impact factor: 6.961

Review 8.  The increased susceptibility of women to multiple sclerosis.

Authors:  P Duquette; J Pleines; M Girard; L Charest; M Senecal-Quevillon; C Masse
Journal:  Can J Neurol Sci       Date:  1992-11       Impact factor: 2.104

9.  Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.

Authors:  Kimberly Goldapple; Zindel Segal; Carol Garson; Mark Lau; Peter Bieling; Sidney Kennedy; Helen Mayberg
Journal:  Arch Gen Psychiatry       Date:  2004-01

Review 10.  Cognitive impairment in multiple sclerosis.

Authors:  Nancy D Chiaravalloti; John DeLuca
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.